Clinical Trials Logo

Clinical Trial Summary

The "Analgesia Nociception Index" (ANI; MetroDoloris Medical Systems, Lille, France), derived from an electrocardiogram (ECG) trace, has been proposed as a noninvasive guide to analgesia. The ANI monitor calculates HR variation with respiration, a response mediated primarily by changes in the parasympathetic nervous system (PNS) stimulation to the sinoatrial node of the heart. The aim of this study is to determine the relation between ANI monitor values and serum catecholamine levels. We will compare the serum catecholamine (norepinephrine, epinephrine) levels of conventional nociception control group and ANI-monitor guided nociception control group at the end of surgery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Patients Undergoing Total Laparoscopic Hysterectomy

NCT number NCT04343638
Study type Interventional
Source Yonsei University
Contact
Status Completed
Phase N/A
Start date May 8, 2020
Completion date October 28, 2021